People

Search Language

日本語 / Japanese | Use language selector above (below, on mobile) to search additional languages

1354 items matching filters

Search Results

740

Practice:

  • Technology & Innovation Sector
  • 知的財産
  • 日本

Steven J. Routh パートナー

Washington DC

スティーブン・ルース弁護士はワシントンDCオフィスのパートナー。特許侵害、商品取引、反トラスト、不正競争、製造物責任(PL)、専門職業人賠償責任、および契約や不正行為の申立てを含む様々な分野における複雑な訴訟事件の経験が豊富である。さらに、連邦法および州法違反の潜在的可能性についてクライアントの社内調査および助言も行う。

米国最高峰の法廷弁護士組織と広く認識され、メンバーシップは米国各州の弁護士数全体の1パーセント以下に限られるAmerican College of Trial Lawyersのメンバー。全米の多数の連邦裁判所および州裁判所における裁判で主任弁護士を務めている。更に、事件を公判前にクライアントに有利な条件にて却下または和解に持ち込むことでも数多くの成功を収めている。殆どの合衆国控訴裁判所において書面および口頭弁論の経験を有する。

連邦裁判所および米国国際貿易委員会(ITC)第337条訴訟における特許侵害訴訟において、原告ならびに被告を弁護。また、大手エネルギー企業を代理し、連邦政府捜査に対する返答ならびに市場操作、不正競争、反トラスト法違反などの民間企業からの申し立てに対する弁護を指揮する。さらに、大手金融機関、大手法律事務所、大学、ならびに公立学校区教育委員会を代理し訴訟事件や内部調査を担当する。地方裁判所バージニア東部地区での陪審審理においては主任弁護士を多数件務め、同裁判所の「ロケットドケット」を熟知し得意とする。

代表的な訴訟事件例
  • 半導体フラッシュメモリに関する特許の侵害容疑が関与するITC第337条訴訟手続きにおける正式事実審理での原告側主任弁護士。
  • 消費者エレクトロニクス製品の大手製造会社に対する特許侵害申立てに関与した連邦地方裁判所での陪審審理における被告側主任弁護士。
  • 米国最大手の学生ローン会社に対する、契約違反・不法行為に関する陪審審理及び控訴審における原告側主任弁護士。College Loan Corp. v. SLM Corp. 396 F.3d 7 (4th Cir.)
  •  医療機器製造販売会社に対する陪審審理を含む一連の製造物責任関連訴訟事件における被告側主任弁護士。
  • ITC第337条訴訟手続きにおける原告側主任弁護士。結果、正式事実審理後、特許侵害の事実認定と半導体製造会社に対する排斥命令がもたらされた。

Practice:

  • Technology & Innovation Sector
  • Technology Companies Group

Jake Routhier Corporate Innovation Attorney

サンフランシスコ

Jake also represents high growth technology companies in several areas, including corporate and securities law, formation, and venture capital financings.
Jake received his JD/MBA from the University of Pennsylvania Law School and the Wharton School of Business in 2018, where he received the Academic Excellence Fellowship. He is also a 2010 graduate of Dartmouth College and prior to attending law school worked at education startups in New York.

449696

Practice:

  • Employment Law & Litigation
  • 差別、ハラスメント、報復
  • Wage and Hour

Miranda Rowley マネージング・アソシエイト

サンフランシスコ

Miranda has experience defending clients in all stages of litigation on a broad range of employment law issues. She has significant experience regarding independent contractor misclassification matters, including both single plaintiff and class action litigation involving wage and hour claims, and representative actions under California's Private Attorneys General Act. Miranda also has particular expertise in defending clients in whistleblower retaliation cases.

In addition to her litigation practice, Miranda also counsels clients on California's complex employment laws.

Ari Roytenberg シニア・アソシエイト

New York

Ari's experience includes supervising cases through all phases of litigation, from pre-litigation strategy through appeal. Most recently, Ari served as lead counsel to an aerospace defense company in litigation that began in New York State court and continued through a six-month trial in bankruptcy court in connection with a $1.3 billion restructuring transaction. His courtroom advocacy, briefing strategies, and fact and expert depositions have helped secure favorable outcomes to a number of clients involved in high-stakes disputes.

Before joining Orrick, Ari was an associate with Quinn Emanuel Urquhart & Sullivan LLP and served as a law clerk to Judge Richard M. Berman on the United States District Court for the Southern District of New York.

450076

Practice:

  • 知的財産
  • Patents
  • Life Sciences & HealthTech
  • Supreme Court & Appellate

Irena Royzman, Ph.D. パートナー

New York

With a Ph.D. in biology from MIT and the Whitehead Institute, where she was a NSF fellow, Irena represents plaintiffs and defendants in their most complex pharmaceutical and biotech patent cases. Over the last 20 years, pharmaceutical and biotechnology innovators have relied on Irena again and again for cases involving small molecules, biologics, recombinant DNA technology, gene therapy, gene editing, manufacturing processes, formulations and drug-eluting medical devices, including numerous multi-billion dollar cases involving many of the world’s best-selling drugs.

Irena has significant experience in litigation under the Hatch-Waxman Act (ANDA and 505(b)(2) actions) and the Biologics Price Competition and Innovation Act (BPCIA), as well as inter partes review (IPR) proceedings, license disputes and matters with parallel ex-U.S. litigation and proceedings in foreign patent offices. Irena also helps life sciences companies and organizations develop the law in the most important cases for the biopharma industry. She has been principal counsel on numerous amicus briefs to the United States Supreme Court and the Federal Circuit in key biopharma cases.

For plaintiffs, Irena has successfully defended generic challenges to patents protecting blockbuster medical therapies, including multi-billion dollar cancer, antiviral, diabetes and anti-psychotic drugs, including recently obtaining attorneys’ fees in a hard-fought ANDA action. She also represents innovators in biosimilar litigation from its outset, including in some of the first cases under the BPCIA involving antibodies. Irena also represents clients in innovator vs innovator disputes. For defendants, she defeated a $530 million claim of patent infringement of a competitor’s biotech patent, obtaining dismissal of all claims and discovery sanctions against the patent owner. In another high-stakes case, she obtained summary judgment of noninfringement and exclusion of plaintiff’s experts under Daubert as well as a full award of attorneys’ fees. A registered patent attorney, Irena also handles inter partes review (IPR) proceedings. For patent owners, she has obtained denial of IPR for patents protecting blockbuster drugs and has leveraged IPR for defendants to obtain freedom to operate.

Irena also coordinates U.S. proceedings with parallel ex-U.S. litigation and proceedings in foreign patent offices, recently obtaining freedom to operate for a biotech innovator’s gene therapy. She provides strategic counseling in biologics and pharmaceuticals and advises clients on their IP portfolios and transactions. Irena also represents clients in high-stakes license disputes involving biotech patents, and, in a dispute concerning the use of a recombinant protein as an enzyme replacement therapy, obtained one of the largest settlement awards over the life of the contract.

Chambers USA has recognized Irena as a leading lawyer in intellectual property, where clients have described her as “excellent,” “knowledgeable, aggressive,” “knows the science forward and backward” and “an incredibly smart lawyer.” Benchmark Litigation named her one of the “Top 250 Women in Litigation” for the last eight years and a litigation star in intellectual property. Irena was also named to the Crain’s New York Business list of “Notable Women in Law.” She is also recognized as a leading lawyer by Legal 500. Irena writes and lectures widely on biopharma patent issues and biosimilar litigation. Irena also is frequently quoted on patent-related issues, including in the Washington Post, Financial Times, Nature Biotechnology, Bloomberg and Pink Sheet.

740

Practice:

  • Supreme Court & Appellate

Daniel A. Rubens パートナー

New York

Danny's practice focuses on appellate litigation. He has led the drafting on dozens of appellate briefs, and regularly argues appeals in state and federal courts. Danny has extensive trial litigation experience as well, with an emphasis on dispositive motions, preserving appellate issues, and developing creative legal strategies.

Danny’s work has covered a wide range of subject areas, including securities, bankruptcy, intellectual property, arbitration, class actions, and criminal law. He has a deep understanding of appeals and critical motions in financial services litigation, and in recent years has played a key role in representing financial institutions in major RMBS cases brought by trustees, investors, and monoline insurers. His financial services clients include Credit Suisse, Goldman Sachs, Mr. Cooper, and Ocwen. He also represents leading technology companies in precedent-setting cases involving antitrust law and ballot initiatives, as well as other complex commercial litigation.  In addition, Danny is an experienced bankruptcy litigator, having represented various debtors and creditors in fraudulent transfer cases and other contested insolvency-related matters involving U.S. and foreign law.

Danny is a member of the Second Circuit's pro bono panel and maintains an active pro bono practice focusing on criminal, immigration, racial justice, and LGBTQ+ rights matters in the Supreme Court and other appellate courts. He was recently recognized by the National LGBTQ+ Bar Association as a “Best LGBTQ+ Lawyer Under 40,” by the New York Law Journal as a Rising Star, and by LawDragon in its inaugural 500 X – The Next Generation listing.  As part of his commitment to diversity, equity, and inclusion, Danny serves as a mentor for The Appellate Project, an organization focused on empowering law students of color to thrive in the appellate field. He has also served as an Orrick ambassador for the Move The Needle Fund, a collaborative effort designed by Diversity Lab to create a more diverse and inclusive legal profession.

Before joining Orrick, Danny served as a law clerk to U.S. Supreme Court Justice Ruth Bader Ginsburg, Judge Robert A. Katzmann of the U.S. Court of Appeals for the Second Circuit, and Judge Jed S. Rakoff of the U.S. District Court for the Southern District of New York. Following his clerkships, he was selected to represent the American Inns of Court as a Temple Bar Scholar in London.

Practice:

  • Technology Companies Group
  • Mergers and Acquisitions

Dr. Johannes Rüberg, EMBA パートナー

ミュンヘン

This includes venture and growth financings in all stages and general corporate counseling. His practice further focuses on advising strategic and financial investors on mergers and acquisitions.

Germany's leading legal directory JUVE lists Johannes as frequently recommended for both corporate law and venture capital, including a competitor's testimonial "very good expertise, pleasant cooperation" (2024/2025). Legal 500 Deutschland lists Johannes as a "recommended lawyer" for venture capital (2024), including the testimonials "very supportive and a pleasure to work with", "extremely conscientious", and "quick response time" in its 2022 edition. Since 2021, he has been recognized by Germany's leading business daily Handelsblatt as a "Ones to Watch" lawyer for corporate law.

In addition to his work as a lawyer, Johannes has completed the joint Executive MBA program by U.S.-based Kellogg University and WHU – Otto Beisheim School of Management, Germany’s leading startup university.

Practice:

  • 複雑な訴訟および紛争処理
  • Securities Litigation
  • Mass Torts & Product Liability

Aaron M. Rubin パートナー

オレンジ・カウンティ

An accomplished litigator, Aaron advises leading investment banks, financial institutions, mortgage servicers, non-bank lenders, and alternative asset managers on the unique issues impacting the finance sector, from major commercial disputes to securities litigation and enforcement actions. Leveraging his dispute resolution expereince, Aaron serves as a trusted partner to clients, advising on best practices for mitigating risk long before there is the threat of litigation.

In 2018, Aaron moved to the firm’s Orange County office from New York. The move served his New York-based traditional financial institution clients needing counsel on the West Coast, while also expanding his practice.

740

Practice:

  • Mergers and Acquisitions
  • Capital Markets
  • ラテン・アメリカ
  • Life Sciences & HealthTech

David M. Ruff パートナー

New York

David advises private equity funds, their portfolio companies and a broad range of public and private technology, energy and life sciences companies in domestic and cross-border M&A, minority and majority investments, joint ventures and other complex transactions.
740

Practice:

  • Finance Sector
  • White Collar, Investigations, Securities Litigation & Compliance
  • 証券訴訟、集団代表訴訟および株主代表訴訟
  • Financial Services Litigation
  • 政府による調査および強制措置
  • 内部調査

Paul F. Rugani パートナー

オレンジ・カウンティ; New York; シアトル

Legal 500 touts Paul as a recommended attorney for Securities Litigation, observing that he is “among the most creative and strategic lawyers” who always has “an eye on the end game.”  Paul achieved American Lawyer Litigator of the Week recognition as part of a team that achieved a ground-breaking New York Court of Appeals victory that substantially reduced financial exposure in RMBS repurchase litigation.

Leader of Orrick's Securities Litigation practice and deputy leader of the Firm's Financial Services Litigation practice, Paul has extensive experience representing clients in securities class actions, shareholder derivative lawsuits, commercial contractual disputes and other complex litigation matters at both the trial and appellate levels, as well as in connection with internal, government and regulatory investigations. Paul also counsels domestic and foreign accounting firms on matters related to state CPA licensing and state board regulation.

740

Practice:

  • Technology & Innovation Sector

Michael Ruiz パートナー

シリコン・バレー; シアトル

Michael advises his clients on a broad range of legal needs, including corporate formation and structure, venture capital financings, board and stockholder relationships and exit transactions. His current and former clients are concentrated in interactive media industries including game development, Esports, AR/VR tech, 3D animation, and artificial intelligence. Michael also advises companies in the cleantech and life sciences sectors.

His favorite video game is Final Fantasy (VII), favorite board game is Twilight Imperium (IV) and favorite science fiction book is Ender’s Game.

Zoe Russell マネージング・アソシエイト

Los Angeles

Zoe works on diverse employment litigation matters. She is also active in pro bono matters.

Zoe received her J.D. from the University of California, Los Angeles School of Law, where she simultaneously earned her M.A. in African American Studies. While in law school, she served as the Co-Chair for the Black Law Students Association and the Director of Affordable Housing for the UCLA Graduate Students Association.